SCHEMBL387010

SCHEMBL387010

O=CC1CC[CH]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL385719 0.85
SCHEMBL2878395 0.84
SCHEMBL3392956 0.81
SCHEMBL4848 0.75
SCHEMBL887195 0.75 ADH1A (0.32)
SCHEMBL887222 0.75 ADH1A (0.32)
SCHEMBL823159 0.75 ADH1A (0.32)
SCHEMBL6347535 0.73
SCHEMBL1230434 0.73 ALDH1A1 (0.39)
SCHEMBL1230432 0.73 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113214342-A 23-hydroxy betulinic acid 3-site modified derivative, preparation method and application 中国药科大学 2021-08-06 CN claimed
CN-101253148-B Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use XENOPORT INC 2013-01-02 CN claimed
CN-101253148-A Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use XENOPORT INC (US) 2008-08-27 CN claimed
CN-113214342-B 23-hydroxy betulinic acid 3-site modified derivative, preparation method and application 中国药科大学 2022-05-24 CN disclosed
CN-114206872-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR8 agonists 百济神州有限公司 2022-03-18 CN disclosed
CN-113214342-A 23-hydroxy betulinic acid 3-site modified derivative, preparation method and application 中国药科大学 2021-08-06 CN disclosed
CN-112513043-A Broad spectrum carbapenems 维纳拓尔斯制药公司 2021-03-16 CN disclosed
CN-112321590-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR8 agonists 百济神州有限公司 2021-02-05 CN disclosed
CN-107501380-B 23-hydroxy betulinic acid 23-position modified derivative, preparation method and application thereof 中国药科大学 2020-09-29 CN disclosed
CN-107429059-A ENERGY-SENSITIVE RESIN COMPOSITION 东京应化工业株式会社 2017-12-01 CN disclosed
CN-106575080-A Energy-sensitive resin composition 东京应化工业株式会社 2017-04-19 CN disclosed
US-20040132784-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2004-07-08 US disclosed
EP-1434782-A2 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF University of Virginia Patent Foundation (US) 2004-07-07 EP disclosed
US-6723745-B2 PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL SANKYO COMPANY, LIMITED (JP) 2004-04-20 US disclosed
US-20030236297-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2003-12-25 US disclosed
WO-2003086408-A1 USE OF A2A ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2003-10-23 WO disclosed
US-20030186926-A1 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-10-02 US disclosed
WO-2003029264-A2 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2003-04-10 WO disclosed
EP-1300405-A1 AMINO ALCOHOL DERIVATIVES Sankyo Company, Limited (JP) 2003-04-09 EP disclosed
US-4898455-A Pyridine liquid crystalline compounds HOFFMANN-LA ROCHE INC. (US) 1990-02-06 US disclosed